MCL1 and cancer: A high expression level of MCL-1 in cancer cells changes the balance of proapoptotic and antiapoptotic proteins, which prevents cancer cells from programmed apoptosis, leading to malignant cell proliferation.62 Therefore, developing MCL-1 inhibitors could be a potential therapeutic approach for cancer treatment.